Literature DB >> 31632814

Pancreatic PCSK9 and its involvement in diabetes.

Maaike Kockx1, Leonard Kritharides1,2.   

Abstract

Entities:  

Year:  2019        PMID： 31632814      PMCID： PMC6783777          DOI： 10.21037/jtd.2019.06.37

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  28 in total

1.  Low density lipoprotein binding and uptake by human and rat islet beta cells.

Authors:  A Y Grupping; M Cnop; C F Van Schravendijk; J C Hannaert; T J Van Berkel; D G Pipeleers
Journal:  Endocrinology       Date:  1997-10       Impact factor: 4.736

2.  Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients.

Authors:  Kwang Kon Koh; Michael J Quon; Seung Hwan Han; Yonghee Lee; Soo Jin Kim; Eak Kyun Shin
Journal:  J Am Coll Cardiol       Date:  2010-03-23       Impact factor: 24.094

3.  Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus.

Authors:  Joost Besseling; John J P Kastelein; Joep C Defesche; Barbara A Hutten; G Kees Hovingh
Journal:  JAMA       Date:  2015-03-10       Impact factor: 56.272

4.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Authors:  C Baigent; A Keech; P M Kearney; L Blackwell; G Buck; C Pollicino; A Kirby; T Sourjina; R Peto; R Collins; R Simes
Journal:  Lancet       Date:  2005-09-27       Impact factor: 79.321

5.  PCSK9-deficient mice exhibit impaired glucose tolerance and pancreatic islet abnormalities.

Authors:  Majambu Mbikay; Francine Sirois; Janice Mayne; Gen-Sheng Wang; Andrew Chen; Thilina Dewpura; Annik Prat; Nabil G Seidah; Michel Chretien; Fraser W Scott
Journal:  FEBS Lett       Date:  2009-12-16       Impact factor: 4.124

6.  Insulin-secreting beta-cell dysfunction induced by human lipoproteins.

Authors:  Marc-Estienne Roehrich; Vincent Mooser; Vincent Lenain; Joachim Herz; Johannes Nimpf; Salman Azhar; Martine Bideau; Alessandro Capponi; Pascal Nicod; Jacques-Antoine Haefliger; Gérard Waeber
Journal:  J Biol Chem       Date:  2003-02-18       Impact factor: 5.157

7.  Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration.

Authors:  Ahmed Zaid; Anna Roubtsova; Rachid Essalmani; Jadwiga Marcinkiewicz; Ann Chamberland; Josée Hamelin; Michel Tremblay; Hélène Jacques; Weijun Jin; Jean Davignon; Nabil G Seidah; Annik Prat
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

8.  Genetic and metabolic determinants of plasma PCSK9 levels.

Authors:  Susan G Lakoski; Thomas A Lagace; Jonathan C Cohen; Jay D Horton; Helen H Hobbs
Journal:  J Clin Endocrinol Metab       Date:  2009-04-07       Impact factor: 5.958

9.  PCSK9 is expressed in pancreatic delta-cells and does not alter insulin secretion.

Authors:  Cédric Langhi; Cédric Le May; Valéry Gmyr; Brigitte Vandewalle; Julie Kerr-Conte; Michel Krempf; François Pattou; Philippe Costet; Bertrand Cariou
Journal:  Biochem Biophys Res Commun       Date:  2009-10-28       Impact factor: 3.575

10.  Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes.

Authors:  Brian A Ference; Jennifer G Robinson; Robert D Brook; Alberico L Catapano; M John Chapman; David R Neff; Szilard Voros; Robert P Giugliano; George Davey Smith; Sergio Fazio; Marc S Sabatine
Journal:  N Engl J Med       Date:  2016-12-01       Impact factor: 91.245
View more
  1 in total

1.  In silico identification of single nucleotide variations at CpG sites regulating CpG island existence and size.

Authors:  Nivas Shyamala; Chaitra Lava Kongettira; Kaushik Puranam; Keerthi Kupsal; Ramanjaneyulu Kummari; Chiranjeevi Padala; Surekha Rani Hanumanth
Journal:  Sci Rep       Date:  2022-03-04       Impact factor: 4.996
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.